Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway - PubMed (original) (raw)
Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway
Z Q Yao et al. J Immunol. 2001.
Abstract
Complement proteins are involved in early innate immune responses against pathogens and play a role in clearing circulating viral Ags from the blood of infected hosts. We have previously demonstrated that hepatitis C virus (HCV) core, the first protein to be expressed and circulating in the blood of infected individuals, inhibited human T cell proliferative response through interaction with the complement receptor, globular domain of C1q receptor (gC1qR). To investigate the mechanisms of HCV core/gC1qR-induced inhibition of T cell proliferation, we examined the effect of core protein on the early events in T cell activation. We found that HCV core inhibited phosphorylation of extracellular signal-regulated kinase (ERK) and mitogen-activated ERK kinase (MEK). HCV core-induced impairment of ERK/MEK mitogen-activated protein kinase resulted in the inhibition of IL-2 and IL-2Ralpha gene transcription, which led to the inhibition of IL-2 production and high-affinity IL-2R expression. Importantly, the ability of anti-gC1qR Ab treatment to reverse HCV core-induced inhibition of ERK/MEK phosphorylation reveals that the interaction between HCV core and gC1qR is linked to the interference of ERK/MEK mitogen-activated protein kinase activation. These results imply that HCV core-induced blockage of intracellular events in T cell activation by a complement-dependent regulatory pathway may play a critical role in the establishment of HCV persistence during the acute phase of viral infection.
Similar articles
- Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Kittlesen DJ, et al. J Clin Invest. 2000 Nov;106(10):1239-49. doi: 10.1172/JCI10323. J Clin Invest. 2000. PMID: 11086025 Free PMC article. - Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.
Yao ZQ, Eisen-Vandervelde A, Waggoner SN, Cale EM, Hahn YS. Yao ZQ, et al. J Virol. 2004 Jun;78(12):6409-19. doi: 10.1128/JVI.78.12.6409-6419.2004. J Virol. 2004. PMID: 15163734 Free PMC article. - Hepatitis C virus: immunosuppression by complement regulatory pathway.
Yao ZQ, Ray S, Eisen-Vandervelde A, Waggoner S, Hahn YS. Yao ZQ, et al. Viral Immunol. 2001;14(4):277-95. doi: 10.1089/08828240152716547. Viral Immunol. 2001. PMID: 11792059 Review. - HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1.
Yao ZQ, Eisen-Vandervelde A, Ray S, Hahn YS. Yao ZQ, et al. Virology. 2003 Sep 15;314(1):271-82. doi: 10.1016/s0042-6822(03)00419-7. Virology. 2003. PMID: 14517080 - The C1q and gC1qR axis as a novel checkpoint inhibitor in cancer.
Ghebrehiwet B, Zaniewski M, Fernandez A, DiGiovanni M, Reyes TN, Ji P, Savitt AG, Williams JL, Seeliger MA, Peerschke EIB. Ghebrehiwet B, et al. Front Immunol. 2024 Apr 22;15:1351656. doi: 10.3389/fimmu.2024.1351656. eCollection 2024. Front Immunol. 2024. PMID: 38711524 Free PMC article. Review.
Cited by
- A tick C1q protein alters infectivity of the Lyme disease agent by modulating interferon γ.
Tang X, Arora G, Matias J, Hart T, Cui Y, Fikrig E. Tang X, et al. Cell Rep. 2022 Nov 22;41(8):111673. doi: 10.1016/j.celrep.2022.111673. Cell Rep. 2022. PMID: 36417869 Free PMC article. - Hepatitis C Virus-Related Central and Peripheral Nervous System Disorders.
Moretti R, Giuffrè M, Merli N, Caruso P, Di Bella S, Tiribelli C, Crocè LS. Moretti R, et al. Brain Sci. 2021 Nov 27;11(12):1569. doi: 10.3390/brainsci11121569. Brain Sci. 2021. PMID: 34942871 Free PMC article. Review. - SARS-CoV-2 Exacerbates COVID-19 Pathology Through Activation of the Complement and Kinin Systems.
Savitt AG, Manimala S, White T, Fandaros M, Yin W, Duan H, Xu X, Geisbrecht BV, Rubenstein DA, Kaplan AP, Peerschke EI, Ghebrehiwet B. Savitt AG, et al. Front Immunol. 2021 Nov 5;12:767347. doi: 10.3389/fimmu.2021.767347. eCollection 2021. Front Immunol. 2021. PMID: 34804054 Free PMC article. - HCV Core Protein Induces Chemokine CCL2 and CXCL10 Expression Through NF-κB Signaling Pathway in Macrophages.
Song X, Gao X, Wang Y, Raja R, Zhang Y, Yang S, Li M, Yao Z, Wei L. Song X, et al. Front Immunol. 2021 Aug 31;12:654998. doi: 10.3389/fimmu.2021.654998. eCollection 2021. Front Immunol. 2021. PMID: 34531848 Free PMC article. - Virus-Encoded Complement Regulators: Current Status.
Sinha A, Singh AK, Kadni TS, Mullick J, Sahu A. Sinha A, et al. Viruses. 2021 Jan 29;13(2):208. doi: 10.3390/v13020208. Viruses. 2021. PMID: 33573085 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous